Investment
Features
FeesSafety
Academy
More
Pluang+

Aave plans to raise GHO borrowing rates on Ethereum, making loans costlier to encourage repayments.

Protocol Fundamentals
05 Oct 2026
Tokenpost
View Source
Neutral
Aave plans to raise GHO borrowing rates on Ethereum, making loans costlier to encourage repayments.

Aave has proposed increasing the borrowing rates for its GHO stablecoin on Ethereum to make loans more expensive and encourage borrowers to repay. The annual rate on Ethereum's Core market would rise from 4.25% to 4.50%, matching the Aave Savings Rate, while the Ethereum Prime base rate would increase from 2.75% to 3%. This change aims to close a gap where borrowers could profit by borrowing at a lower rate and depositing at a higher savings rate, which previously caused losses to the DAO. Higher borrowing costs may lead to more repayments, helping replenish the depleted USDC reserves in the Stability Modules and supporting future institutional lending plans using GHO.

The Aave proposal to raise GHO borrowing rates is presented here with a snapshot of Pluang's cryptocurrency market. For readers following major cryptocurrencies, as of Oct 06, 2026 01:32 WIB, 25 out of 50 major cryptocurrencies rose while 24 fell. Among notable movers, EOS increased by 8.13% to Rp12.649 with a typical hold time of 87 days, ADA rose 6.77% to Rp4.732 with 60% buy order activity and a typical hold time of 126 days, and FIL gained 6.30% to Rp19.598 with 80% buy order activity and a typical hold time of 99 days.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
1 hour ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
2 hours ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
3 hours ago
Aptos Labs proposes encrypted mempool to protect pending trades, adding 27ms latency if approved by governance.

Aptos Labs proposes encrypted mempool to protect pending trades, adding 27ms latency if approved by governance.

Aptos Labs has proposed an encrypted mempool feature that hides pending trade instructions until transaction ordering is complete, aiming to protect orders from frontrunning and censorship. Tests showed the feature adds 27 milliseconds of latency, ab...

Protocol Fundamentals
Bullish
4 hours ago
Pacific Booker plans $10M private placement to fund Morrison project development.

Pacific Booker plans $10M private placement to fund Morrison project development.

Pacific Booker Minerals Inc. announced a non-brokered private placement to raise up to $10 million by selling 4,273,505 units at $2.34 each. Each unit includes one common share and one warrant to buy another share at $2.75 within 36 months. The funds...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App